Chemerin’s involvement in atherosclerosis is further evidenced by its ability to enhance leukocyte adhesion and migration via β2 integrins and extracellular signal-regulated kinase 1/2 (ERK1/2) signalling [43]. This evidence concerns the gene MAPK3 and atherosclerosis.